STOCK TITAN

Exact Sciences to participate in May investor conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

MADISON, Wis., May 3, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • BofA Securities Virtual Healthcare Conference
    Fireside Chat on Wednesday, May 12, 2021 at 1:15 p.m. EDT
     
  • UBS Global Healthcare Virtual Conference
    Fireside Chat on Tuesday, May 25, 2021 at 4:00 p.m. EDT

The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.

About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com 
608-535-8815

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-may-investor-conferences-301281678.html

SOURCE EXACT SCIENCES CORP

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

11.41B
179.56M
1.01%
89.38%
3.49%
Diagnostic Imaging Centers
Health Care and Social Assistance
Link
United States of America
MADISON

About EXAS

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com